top of page
About Overview

About Us


Vergent Bioscience has a world-class management team with a track record of successfully developing groundbreaking medical technologies that transform patient care.

Leadership Team
Vergent Bio Leadership_John T. Santini.jpg
John Santini, PhD

President & Chief Executive Officer

Alix Alderman

Chief Regulatory Officer

Vergent Bio Leadership_Eric Bensen_2.jpg
Eric Bensen, PhD

Vice President, Research and Development

Vergent Bio Leadership Maggie Neptune.jpg
Maggie Neptune

Vice President, Clinical Operations

Vergent Bio Leadership Andrea Simpson.jpg
Andrea Simpson

Vice President, Strategic Marketing

Vergent Bio Leadership_Curtis Scribner.jpg
Curtis Scribner, MD

Chief Medical Officer

Board of Directors

Our board of directors and advisors include world-class surgeons, scientists, and biotech executives committed to revisualizing cancer surgery

Vergent Bio Board_Dean Banks.jpg
Dean Banks

Co-founder, Board Member

Tyson Foods, Google X, Highland Capital Partners, OrthoHelix, Tornier, J&J, Harvard

Vergent Bio Board_Ryan Egeland.jpg
Ryan Egeland, MD, PhD

Board Member

Crossfire Medical, Cardiovascular Systems Inc, Medtronic, Harvard, Oxford (Rhodes Scholar)

Vergent Bio Board_Bobby Helmedag.jpg
Bobby Helmedag

Board Member

Rex Health Ventures, BlueCross BlueShield of Tennessee, Tomlinson Family Office, Citigroup, KPMG, University of Notre Dame

Vergent Bio Board_Doug Kohrs.jpg
Doug Kohrs

Board Member

Responsive Orthopedics, spineTECH, Tornier, American Medical Systems

Vergent Bio Board_Jeff Julkowski.jpg
Jeff Julkowski

Co-founder, Board Member

Chamilia, Morgan Stanley and Salomon SmithBarney/Citigroup, West Point

Vergent Bio Board_Raymond Wong.jpg
Raymond Wong

Board Member

Spring Mountain Capital, Merrill Lynch, Harvard

Vergent Bio Leadership_John T. Santini.jpg
John Santini, PhD

Board Member

Vergent Bioscience, ApoGen Biotechnologies, MicroCHIPS Biotech, MIT

bottom of page